Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | SRA Run Selector | Stephen Tapscott | ||||||
GSE43223 |
Alternate exon switching establishes a tissue-specific transcription factor to mediate temporal activation of gene expression during differentiation
|
4 | Stephen Tapscott | Jun 01, 2013 | ||||
GSE188926 |
Canine DUXC isoforms and functional similarity to human DUX4 [ChIP-seq]
|
5 | Stephen Tapscott | Dec 03, 2021 | ||||
GSE188927 |
Canine DUXC isoforms and functional similarity to human DUX4 [RNA-seq]
|
12 | Stephen Tapscott | Dec 03, 2021 | ||||
GSE50413 |
Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors (MyoD ChIP-Seq profiling)
|
4 |
|
Stephen Tapscott | Aug 29, 2013 | |||
GSE87279 |
Conservation and innovation in the DUX4-family gene network (ChIP-seq)
|
5 |
|
Stephen Tapscott | Feb 01, 2017 | |||
GSE87266 |
Conservation and innovation in the DUX4-family gene network (RNA-seq)
|
18 |
|
Stephen Tapscott | Feb 01, 2017 | |||
GSE93168 |
Conservation and innovation in the DUX4-family gene network [MMH6 ChIP-Seq]
|
2 |
|
Stephen Tapscott | Feb 01, 2017 | |||
GSE93167 |
Conservation and innovation in the DUX4-family gene network [MMH6 RNA-Seq]
|
6 |
|
Stephen Tapscott | Feb 01, 2017 | |||
GSE64626 |
Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage [ChIP-seq]
|
12 |
|
Stephen Tapscott | Jul 31, 2015 | |||
GSE64622 |
Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage [RNA-seq]
|
8 |
|
Stephen Tapscott | Jul 31, 2015 | |||
GSE33838 |
DUX4 activates germline genes, retroelements and immune-mediators: Implications for facioscapulohumeral dystrophy
|
2 | Stephen Tapscott | Jan 03, 2012 | ||||
GSE87495 |
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy
|
6 | Stephen Tapscott | Dec 31, 2016 | ||||
GSE56787 |
DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle
|
38 |
|
Stephen Tapscott | Jul 03, 2014 | |||
GSE119401 |
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (CUT&RUN)
|
8 | Stephen Tapscott | Aug 31, 2019 | ||||
GSE119402 |
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq)
|
15 | Stephen Tapscott | Aug 31, 2019 | ||||
GSE114936 |
DUX4-induced transcripts from pericentric human satellite II repeats form double-stranded RNA [dsRIPseq]
|
18 | Stephen Tapscott | Oct 30, 2019 | ||||
GSE114938 |
DUX4-induced transcripts from pericentric human satellite II repeats form double-stranded RNA [stranded-RNAseq]
|
4 | Stephen Tapscott | Oct 30, 2019 | ||||
GSE25000 |
Differential genomic targeting of the transcription factor TAL1 in alternate hematopoietic lineages
|
3 | Stephen Tapscott | Oct 30, 2010 | ||||
GSE75370 |
Distinct activities of Myf5 and MyoD indicate sequential roles in skeletal muscle lineage specification and differentiation (ChIP-Seq)
|
10 |
|
Stephen Tapscott | Mar 01, 2016 | |||
GSE75631 |
Distinct activities of Myf5 and MyoD indicate sequential roles in skeletal muscle lineage specification and differentiation (RNA-Seq)
|
12 |
|
Stephen Tapscott | Mar 01, 2016 |